Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Oncologic safety of breast conservation following NACT in women with locally advanced breast cancer

Published: 25 May 2023

Views: 184

Rating:

Save

Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India

Dr Sanjit Agrawal speaks to ecancer about the oncologic safety of breast conservation following NACT in women with locally advanced breast cancer.

He says that this study is a retrospective observational study of 411 non-metastatic locally advanced breast cancer (LABC) patients who received neoadjuvant chemotherapy (NACT) followed by surgery from 2011 to 2016.

The study found that BCS is technically feasible in LABC patients.

Dr Agrawal concludes that LABC patients who respond well to NACT can be offered BCS without compromising survival outcomes.

Read the full study here.

Related Videos

Laser oncosurgery - A new perspective in treating cancer

Dr Rusy Bhalla - Orchid Center For Laser Surgery, Mumbai, India

Laser oncosurgery - A new perspective in treating cancer ( Dr Rusy Bhalla - Orchid Center For Laser Surgery, Mumbai, India )

Trastuzumab deruxtecan effective against brain metastases in HER2-positive...

Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA

Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer ( Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA )

Hormonal receptor positive breast cancer adjuvant and metastatic indications

Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA

Hormonal receptor positive breast cancer adjuvant and metastatic indications ( Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA )

Addition of atezolizumab to chemotherapy after surgery does not improve...

Dr Heather McArthur - UT Southwestern Medical Center, Dallas, USA

Addition of atezolizumab to chemotherapy after surgery does not improve survival for triple negative breast cancer ( Dr Heather McArthur - UT Southwestern Medical Center, Dallas, USA )

Comment: EBCC 2024 highlights

Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr...

Comment: EBCC 2024 highlights ( Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr Michail Ignatiadis (Institut Jules Bordet, Brussels, Belgium) )

Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA

Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA )

SABCS 2023: Highlights

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

SABCS 2023: Highlights ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

Preoperative endocrine therapy in premenopausal women leads to sparing...

Dr Oleg Gluz - Krankenhaus Bethesda, Mönchengladbach, Germany

Preoperative endocrine therapy in premenopausal women leads to sparing chemotherapy in additional patients ( Dr Oleg Gluz - Krankenhaus Bethesda, Mönchengladbach, Germany )

Trial investigates multiparametric prognostic score in early HR+/HER2- breast...

Dr Oleg Gluz - Krankenhaus Bethesda, Mönchengladbach, Germany

Trial investigates multiparametric prognostic score in early HR+/HER2- breast cancer ( Dr Oleg Gluz - Krankenhaus Bethesda, Mönchengladbach, Germany )

More from ecancer